SEI INVESTMENTS CO - OVID THERAPEUTICS INC ownership

OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 63 filers reported holding OVID THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
SEI INVESTMENTS CO ownership history of OVID THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$62,928
+1.5%
33,8320.0%0.00%
Q3 2022$62,000
-60.5%
33,832
-53.6%
0.00%
Q2 2022$157,000
-58.1%
72,988
-38.8%
0.00%
-100.0%
Q1 2022$375,000
-2.1%
119,3540.0%0.00%0.0%
Q4 2021$383,000
+41.3%
119,354
+47.9%
0.00%0.0%
Q3 2021$271,000
-14.2%
80,6970.0%0.00%0.0%
Q2 2021$316,000
+31500.0%
80,697
+83092.8%
0.00%
Q2 2018$1,000970.00%
Other shareholders
OVID THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
AWH Capital, L.P. 230,000$407,0000.69%
BVF INC/IL 3,293,000$5,829,0000.65%
COWEN INC. 1,101,414$1,950,0000.21%
ARMISTICE CAPITAL, LLC 1,780,000$3,151,0000.17%
Granite Point Capital Management, L.P. 417,857$740,0000.07%
Redmile Group, LLC 737,550$1,305,0000.04%
Tekla Capital Management LLC 496,977$880,0000.04%
Fairpointe Capital LLC 101,000$179,0000.01%
Alyeska Investment Group, L.P. 225,000$398,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 84,440$149,0000.00%
View complete list of OVID THERAPEUTICS INC shareholders